reduce insulin dose when starting glp-1 receptor agonist Clinical Focus on Agonists in Type 2 Diabetes Mellitus GLP-1-based therapies for type 2
Description
Patients who have endocrine conditions or rare thyroid conditions should consult their primary doctors before taking these medications, as they may be contraindicated for them
Among the latest advancements in pharmacotherapy for weight management are GLP-1 agonists which have shown promising results in aiding weight loss
doi: 10.1210/en.2008-1221 [DOI] [PMC free article] [PubMed] [Google Scholar] 46.Williams DL, Baskin DG, Schwartz MW
doi: 10.1002/oby.21563 13 SonneNLarsenATAndreassenKVKarsdalMAHenriksenK
